Skip to main content
Premium Trial:

Request an Annual Quote

Dow AgroSciences Grants License to Danforth Center to Improve Cassava Crop

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Dow AgroSciences has granted the Donald Danforth Plant Science Center a non-exclusive sublicense for use of its gene expression technology under a deal announced today.

As part of the agreement, the Danforth Center will be able to use a promoter that allows disease-resistance genes to be introduced and to function in the cassava plant, thereby blocking viral replication.

Cassava is a food source for more than 750 million people and an important income source for small farmers in Africa, Asia, and Latin America. However, it is susceptible to a number of pathogens.

The Scripps Research Institute developed the technology covered by today's deal, and Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, exclusively licenses it. The technology will improve the center's ability to develop cassava that can better withstand viral diseases and improve the productivity of subsistence farmers in Africa, the center said.

Financial and other terms of the deal were not disclosed.

In early 2010, Dow AgroSciences and the Danforth Center began a research collaboration on cassava, and today's agreement provides an addition to crop improvement tools that are already at the center, it said.

The Danforth Center's Claude Fauquet is developing disease-resistance technology aimed at reducing the impact of Cassava Mosaic Disease and Cassava Brown Streak Disease. He and his colleagues at the center are partnering with researchers in Africa to improve, evaluate, and eventually deploy cassava varieties that will reduce losses of cassava from disease and improve food security.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.